Copyright: ©Author(s) 2026.
World J Exp Med. Mar 20, 2026; 16(1): 112270
Published online Mar 20, 2026. doi: 10.5493/wjem.v16.i1.112270
Published online Mar 20, 2026. doi: 10.5493/wjem.v16.i1.112270
Table 1 Multiparametric echocardiographic score for the diagnosis of Cardiac amyloidosis
| Echocardiographic parameter | Diagnostic threshold | Score |
| Relative LV wall thickness (IVS + PWT)/LVEDD | > 0.6 | 3 points |
| E/e’ ratio (Doppler E wave to e’ velocity) | > 11 | 1 point |
| Tricuspid annular plane systolic excursion | ≤ 19 mm | 2 points |
| LV global longitudinal strain absolute value | ≤ -13% | 1 point |
| Systolic longitudinal strain apex-to-base ratio | > 2.9 | 3 points |
Table 2 Perugini scoring system for cardiac amyloid imaging interpretation
| Perugini score | Cardiac uptake | Bone uptake | Interpretation |
| 0 | Absent | Normal | No evidence of cardiac amyloid deposition |
| 1 | Mild, less than bone uptake | Normal | Low-grade uptake, non-specific |
| 2 | Moderate | Reduced | Suggestive of transthyretin cardiac amyloidosis |
| 3 | Strong | Mild or absent | Highly suggestive of transthyretin cardiac amyloidosis |
- Citation: Bouziane M, Moufid O, Habbal R. Cardiac amyloidosis: From diagnosis to therapeutics breakthroughs. World J Exp Med 2026; 16(1): 112270
- URL: https://www.wjgnet.com/2220-315x/full/v16/i1/112270.htm
- DOI: https://dx.doi.org/10.5493/wjem.v16.i1.112270
